Accessibility Menu
Biotech Growth Trust Plc logo

Biotech Growth Trust Plc

(LSE) BIOG

Current Price£14.33
Market Cap£279.66M
Since IPO (1997)+1,246%
5 Year+6%
1 Year+97%
1 Month+9%

Biotech Growth Trust Plc Financials at a Glance

Market Cap

£279.66M

Revenue (TTM)

£59.04M

Net Income (TTM)

£47.59M

EPS (TTM)

£5.58

P/E Ratio

2.59

Dividend

£0.00

Beta (Volatility)

0.00 (Low)

Price

£14.33

Volume

6,746

Open

£14.56

Previous Close

£14.48

Daily Range

£14.30 - £14.56

52-Week Range

£7.02 - £14.56

Estimated Earnings Date

Nov 25, 2025

BIOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotech Growth Trust Plc

Industry

Capital Markets

Employees

0

Headquarters

New York City, NY 10022, US

BIOG Financials

Key Financial Metrics (TTM)

Gross Margin

98.21%

Operating Margin

97.68%

Net Income Margin

96.47%

Return on Equity

48.26%

Return on Capital

44.82%

Return on Assets

43.10%

Earnings Yield

38.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£279.66M

Shares Outstanding

19.31M

Volume

6.75K

Avg. Volume

61.05K

Financials (TTM)

Gross Profit

£55.40M

Operating Income

£52.25M

EBITDA

£51.71M

Operating Cash Flow

-£11.66M

Capital Expenditure

£0.00

Free Cash Flow

-£11.66M

Cash & ST Invst.

£0.00

Total Debt

£12.32M

Biotech Growth Trust Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£63.82M

-29.7%

Gross Profit

£62.50M

-28.6%

Gross Margin

97.93%

N/A

Market Cap

£279.66M

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

£60.83M

-31.1%

EBITDA

£61.66M

-30.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£0.00

-100.0%

Total Debt

£12.32M

-73.8%

Accounts Receivable

£11.00M

-24.2%

Inventory

£0.00

N/A

Long Term Debt

£0.00

N/A

Short Term Debt

£12.32M

-73.8%

Return on Assets

43.10%

N/A

Return on Invested Capital

45.49%

N/A

Free Cash Flow

-£3.46M

-46.0%

Operating Cash Flow

-£3.46M

-46.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DIVI.LThe Diverse Income Trust plc
£1.18+1.29%
IBT.LInternational Biotechnology Trust plc
£10.32+0.16%
BGUK.LBaillie Gifford UK Growth Trust plc
£2.06-0.34%
MTE.LMontanaro European Smaller Companies Trust plc
£1.76-1.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$157.09+0.02%
INTCIntel
$132.39-0.06%
NVDANvidia
$200.32-0.04%
AAPLApple
$294.83-0.01%

Questions About BIOG

What is the current price of Biotech Growth Trust Plc?

Biotech Growth Trust Plc is trading at £14.33 per share.

What is the 52-week range for Biotech Growth Trust Plc?

Over the past 52 weeks, Biotech Growth Trust Plc has traded between £7.02 and £14.56.

How much debt does Biotech Growth Trust Plc have?

As of the most recent reporting period, Biotech Growth Trust Plc reported total debt of £12.32M.

How much cash does Biotech Growth Trust Plc have on hand?

Biotech Growth Trust Plc reported £0.00 in cash and cash equivalents in its most recent financial results.

What is Biotech Growth Trust Plc’s dividend yield?

Biotech Growth Trust Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.